Literature DB >> 26569460

Lack of regional association between atrial late gadolinium enhancement on cardiac magnetic resonance and atrial fibrillation rotors.

Jonathan Chrispin1, Esra Gucuk Ipek2, Sohail Zahid3, Adityo Prakosa3, Mohammadali Habibi2, David Spragg2, Joseph E Marine2, Hiroshi Ashikaga2, John Rickard2, Natalia A Trayanova3, Stefan L Zimmerman4, Vadim Zipunnikov5, Ronald D Berger6, Hugh Calkins2, Saman Nazarian7.   

Abstract

BACKGROUND: The extent of left atrial (LA) late gadolinium enhancement (LGE), as a surrogate for fibrosis, has been associated with atrial fibrillation (AF) recurrence after catheter ablation. Furthermore, there is ex vivo evidence that islands of fibrosis may anchor fibrillatory rotors.
OBJECTIVE: The purpose of this study was to examine the anatomical association of AF rotors with LA and right atrial (RA) LGE on cardiac magnetic resonance.
METHODS: The cohort included 9 patients with persistent AF (mean age 61.1 ± 9.7 years) who underwent LGE cardiac magnetic resonance before AF ablation using the focal impulse and rotor modulation system. The extent of LA and RA LGE was quantified globally and in each of the 7 sectors: LA posterior/inferior wall, anterior wall, roof, left and right pulmonary vein antra, and RA lateral and septal regions. The multivariable association of rotor incidence with global and per sector LGE extent was examined using multivariable Bernoulli logistic regression estimated by generalized estimating equations.
RESULTS: The mean RA and LA volumes were 113.2 ± 37.31 and 143.03 ± 58.25 mL, respectively. The mean RA and LA LGE burden was 17.2% ± 11.0% and 17.4% ± 14.4%, respectively. A total of 18 LA rotors and 9 RA rotors were identified in all patients. No univariable or multivariable association was observed between global or per sector LGE extent and focal impulse and rotor modulation rotor incidence.
CONCLUSION: In this cohort of patients, there was no association between AF rotor incidence and the global or regional extent of RA and LA LGE.
Copyright © 2016 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Delayed enhancement magnetic resonance imaging; Fibrosis; Rotor

Mesh:

Substances:

Year:  2015        PMID: 26569460     DOI: 10.1016/j.hrthm.2015.11.011

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  26 in total

1.  Human Atrial Fibrillation Drivers Resolved With Integrated Functional and Structural Imaging to Benefit Clinical Mapping.

Authors:  Brian J Hansen; Jichao Zhao; Ning Li; Alexander Zolotarev; Stanislav Zakharkin; Yufeng Wang; Josh Atwal; Anuradha Kalyanasundaram; Suhaib H Abudulwahed; Katelynn M Helfrich; Anna Bratasz; Kimerly A Powell; Bryan Whitson; Peter J Mohler; Paul M L Janssen; Orlando P Simonetti; John D Hummel; Vadim V Fedorov
Journal:  JACC Clin Electrophysiol       Date:  2018-11-01

2.  Heterogeneity of the action potential duration is required for sustained atrial fibrillation.

Authors:  Uma Mahesh R Avula; Jeffrey Abrams; Alexander Katchman; Sergey Zakharov; Sergey Mironov; Joseph Bayne; Daniel Roybal; Anirudh Gorti; Lin Yang; Vivek Iyer; Marc Waase; Deepak Saluja; Edward J Ciaccio; Hasan Garan; Andrew R Marks; Steven O Marx; Elaine Y Wan
Journal:  JCI Insight       Date:  2019-04-25

3.  Multimodal Examination of Atrial Fibrillation Substrate: Correlation of Left Atrial Bipolar Voltage Using Multi-Electrode Fast Automated Mapping, Point-by-Point Mapping, and Magnetic Resonance Image Intensity Ratio.

Authors:  Tarek Zghaib; Ali Keramati; Jonathan Chrispin; Dong Huang; Muhammad A Balouch; Luisa Ciuffo; Ronald D Berger; Joseph E Marine; Hiroshi Ashikaga; Hugh Calkins; Saman Nazarian; David D Spragg
Journal:  JACC Clin Electrophysiol       Date:  2017-12-20

4.  A feasibility study of arrhythmia risk prediction in patients with myocardial infarction and preserved ejection fraction.

Authors:  Dongdong Deng; Hermenegild J Arevalo; Adityo Prakosa; David J Callans; Natalia A Trayanova
Journal:  Europace       Date:  2016-12       Impact factor: 5.214

Review 5.  Towards personalized computational modelling of the fibrotic substrate for atrial arrhythmia.

Authors:  Patrick M Boyle; Sohail Zahid; Natalia A Trayanova
Journal:  Europace       Date:  2016-12       Impact factor: 5.214

6.  Modelling methodology of atrial fibrosis affects rotor dynamics and electrograms.

Authors:  Caroline H Roney; Jason D Bayer; Sohail Zahid; Marianna Meo; Patrick M J Boyle; Natalia A Trayanova; Michel Haïssaguerre; Rémi Dubois; Hubert Cochet; Edward J Vigmond
Journal:  Europace       Date:  2016-12       Impact factor: 5.214

Review 7.  Atrial fibrillation driver mechanisms: Insight from the isolated human heart.

Authors:  Thomas A Csepe; Brian J Hansen; Vadim V Fedorov
Journal:  Trends Cardiovasc Med       Date:  2016-05-24       Impact factor: 6.677

Review 8.  Fibrosis and Atrial Fibrillation: Computerized and Optical Mapping; A View into the Human Atria at Submillimeter Resolution.

Authors:  Brian J Hansen; Jichao Zhao; Vadim V Fedorov
Journal:  JACC Clin Electrophysiol       Date:  2017-06-20

9.  Impact of number of co-existing rotors and inter-electrode distance on accuracy of rotor localization.

Authors:  Konstantinos N Aronis; Hiroshi Ashikaga
Journal:  J Electrocardiol       Date:  2017-09-01       Impact factor: 1.438

10.  Relationship Between Fibrosis Detected on Late Gadolinium-Enhanced Cardiac Magnetic Resonance and Re-Entrant Activity Assessed With Electrocardiographic Imaging in Human Persistent Atrial Fibrillation.

Authors:  Hubert Cochet; Rémi Dubois; Seigo Yamashita; Nora Al Jefairi; Benjamin Berte; Jean-Marc Sellal; Darren Hooks; Antonio Frontera; Sana Amraoui; Adlane Zemoura; Arnaud Denis; Nicolas Derval; Frederic Sacher; Olivier Corneloup; Valérie Latrabe; Stéphanie Clément-Guinaudeau; Jatin Relan; Sohail Zahid; Patrick M Boyle; Natalia A Trayanova; Olivier Bernus; Michel Montaudon; François Laurent; Mélèze Hocini; Michel Haïssaguerre; Pierre Jaïs
Journal:  JACC Clin Electrophysiol       Date:  2017-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.